Why the study?
Does drug treatment assessed by arterial mechanical properties offer any clinical advantage in humans?
Does drug treatment assessed by arterial mechanical properties offer any clinical advantage in humans?
The clinical usefulness of measuring drug effects on arterial mechanical properties like pulse wave velocity remains to be established.
Arterial stiffness measures should not yet guide drug therapy; leaves open whether effects are independent of blood pressure reduction.
Arteries become stiffer with increasing age and various disease states. A complete description of arterial mechanical properties in vivo is not possible, although a number of methods have been used. 2. Detailed discussion in the present review is limited to pulse wave velocity and estimates of central waveform morphology derived by the application of a generalized arterial transfer function. 3. Many drugs affect these parameters, either increasing or decreasing apparent stiffness. However, the extent to which changes reflect changes in blood pressure rather than more fundamental vessel wall properties remains unclear. Similarly, it is as yet unknown whether determining the need for, or assessing the effectiveness of, drug treatment by the assessment of arterial mechanical properties will offer any advantage and the usefulness of these techniques as routine clinical tools remains to be established.
No takes yet. Share an insight, caveat, or question.
Hope et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: